-
1
-
-
85040581773
-
Surveillance, Epidemiology, and End Results Program
-
National Cancer Institute. Accessed March 31, 2017
-
National Cancer Institute. Surveillance, Epidemiology, and End Results Program. Breast Cancer Statistics. https://seer.cancer.gov/statfacts/html/breast.html. Accessed March 31, 2017.
-
Breast Cancer Statistics
-
-
-
2
-
-
27244434470
-
Effect of screening and adjuvant therapy on mortality from breast cancer
-
Berry DA, Cronin KA, Plevritis SK, et al; Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353(17):1784-1792.
-
(2005)
N Engl J Med
, vol.353
, Issue.17
, pp. 1784-1792
-
-
Berry, D.A.1
Cronin, K.A.2
Plevritis, S.K.3
-
3
-
-
80054717098
-
Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: A cohort study
-
Kerlikowske K, Hubbard RA, Miglioretti DL, et al; Breast Cancer Surveillance Consortium. Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study. Ann Intern Med. 2011;155(8):493-502.
-
(2011)
Ann Intern Med
, vol.155
, Issue.8
, pp. 493-502
-
-
Kerlikowske, K.1
Hubbard, R.A.2
Miglioretti, D.L.3
-
4
-
-
84939447471
-
Identifying women with dense breasts at high risk for interval cancer: A cohort study
-
Kerlikowske K, Zhu W, Tosteson AN, et al; Breast Cancer Surveillance Consortium. Identifying women with dense breasts at high risk for interval cancer: a cohort study. Ann Intern Med. 2015;162 (10):673-681.
-
(2015)
Ann Intern Med
, vol.162
, Issue.10
, pp. 673-681
-
-
Kerlikowske, K.1
Zhu, W.2
Tosteson, A.N.3
-
5
-
-
84905842097
-
Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline
-
American Society of Clinical Oncology
-
Giordano SH, Temin S, Kirshner JJ, et al; American Society of Clinical Oncology. Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2014;32(19): 2078-2099.
-
(2014)
J Clin Oncol
, vol.32
, Issue.19
, pp. 2078-2099
-
-
Giordano, S.H.1
Temin, S.2
Kirshner, J.J.3
-
6
-
-
84875043185
-
-
Accessed March 31, 2017
-
National Comprehensive Cancer Network Breast Cancer Guidelines. NCCN guidelines and clinical resources. https://www.nccn.org/professionals/physician_gls/default.aspx. Accessed March 31, 2017.
-
NCCN Guidelines and Clinical Resources
-
-
-
7
-
-
85040572205
-
The Dana-Farber CISNET model for breast cancer screening strategies: An update
-
Lee SJ, Li X, Huang H, Zelen M. The Dana-Farber CISNET model for breast cancer screening strategies: an update. Med Decis Making. 2018;38(1s). doi:10.1177/0272989X17741634
-
(2018)
Med Decis Making
, vol.38
, Issue.1 s
-
-
Lee, S.J.1
Li, X.2
Huang, H.3
Zelen, M.4
-
8
-
-
85040597336
-
Simulating the impact of risk-based screening and treatment on breast cancer outcomes with MISCAN-Fadia
-
van den Broek JJ, van Ravesteyn NT, Heijnsdijk EA, de Koning H. Simulating the impact of risk-based screening and treatment on breast cancer outcomes with MISCAN-Fadia. Med Decis Making. 2018;38(1s). doi:10.1177/0272989X17711928
-
(2018)
Med Decis Making
, vol.38
, Issue.1 s
-
-
Van Den Broek, J.J.1
Van Ravesteyn, N.T.2
Heijnsdijk, E.A.3
De Koning, H.4
-
9
-
-
85040637440
-
Structure, function, and applications of the Georgetown-Einstein (GE) breast cancer simulation model
-
Schechter CB, Near AM, Jayasekera J, Chang Y, Mandelblatt JS. Structure, function, and applications of the Georgetown-Einstein (GE) breast cancer simulation model. Med Decis Making. 2018;38(1s). doi:10.1177/0272989X17698685
-
(2018)
Med Decis Making
, vol.38
, Issue.1 s
-
-
Schechter, C.B.1
Near, A.M.2
Jayasekera, J.3
Chang, Y.4
Mandelblatt, J.S.5
-
10
-
-
85040587865
-
A Bayesian simulation model for breast cancer screening, incidence, treatment, and mortality
-
Huang X, Li Y, Song J, Berry D. A Bayesian simulation model for breast cancer screening, incidence, treatment, and mortality. Med Decis Making. 2018;38(1s). doi:10.1177/0272989X17714473
-
(2018)
Med Decis Making
, vol.38
, Issue.1 s
-
-
Huang, X.1
Li, Y.2
Song, J.3
Berry, D.4
-
11
-
-
85040633992
-
Estimating breast cancer progression features and survival by molecular subtype in the absence of screening and treatment
-
Munoz D, Plevritis SK. Estimating breast cancer progression features and survival by molecular subtype in the absence of screening and treatment. Med Decis Making. 2018;38(1s). doi:10.1177/0272989X17743236
-
(2018)
Med Decis Making
, vol.38
, Issue.1 s
-
-
Munoz, D.1
Plevritis, S.K.2
-
12
-
-
85040538606
-
A molecular subtype-specific stochastic simulation model of US breast cancer incidence and mortality trends from 1975 to 2010
-
Munoz D, Xu C, Plevritis S. A molecular subtype-specific stochastic simulation model of US breast cancer incidence and mortality trends from 1975 to 2010. Med Decis Making. 2018;38(1s). doi:10.1177/0272989X17737508
-
(2018)
Med Decis Making
, vol.38
, Issue.1 s
-
-
Munoz, D.1
Xu, C.2
Plevritis, S.3
-
13
-
-
85040567016
-
The University of Wisconsin breast cancer epidemiology simulation model: An update
-
Alagoz O, Ergun MA, Cevik M, et al. The University of Wisconsin breast cancer epidemiology simulation model: an update. Med Decis Making. 2018;38(1s). doi:10.1177/0272989X17711927
-
(2018)
Med Decis Making
, vol.38
, Issue.1 s
-
-
Alagoz, O.1
Ergun, M.A.2
Cevik, M.3
-
14
-
-
72049091776
-
Effects of mammography screening under different screening schedules: Model estimates of potential benefits and harms
-
Mandelblatt JS, Cronin KA, Bailey S, et al; Breast Cancer Working Group of the Cancer Intervention and Surveillance Modeling Network. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med. 2009;151(10):738-747.
-
(2009)
Ann Intern Med
, vol.151
, Issue.10
, pp. 738-747
-
-
Mandelblatt, J.S.1
Cronin, K.A.2
Bailey, S.3
-
15
-
-
84985004003
-
Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality
-
Munoz D, Near AM, van Ravesteyn NT, et al. Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality. J Natl Cancer Inst. 2014;106(11):dju289.
-
(2014)
J Natl Cancer Inst
, vol.106
, Issue.11
, pp. dju289
-
-
Munoz, D.1
Near, A.M.2
Van Ravesteyn, N.T.3
-
16
-
-
84856636292
-
Comparisons between different polychemotherapy regimens for early breast cancer: Meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
-
Peto R, Davies C, Godwin J, et al; Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials. Lancet. 2012;379(9814):432-444.
-
(2012)
Lancet
, vol.379
, Issue.9814
, pp. 432-444
-
-
Peto, R.1
Davies, C.2
Godwin, J.3
-
17
-
-
84941767992
-
The contribution of mammography screening to breast cancer incidence trends in the United States: An updated age-period-cohort model
-
Gangnon RE, Sprague BL, Stout NK, et al. The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model. Cancer Epidemiol Biomarkers Prev. 2015;24(6):905-912.
-
(2015)
Cancer Epidemiol Biomarkers Prev
, vol.24
, Issue.6
, pp. 905-912
-
-
Gangnon, R.E.1
Sprague, B.L.2
Stout, N.K.3
-
18
-
-
85040563033
-
Contribution of breast cancer to overall mortality for US women
-
Gangnon RE, Stout NK, Alagoz O, Hampton JM, Sprague BL, Trentham-Dietz A. Contribution of breast cancer to overall mortality for US women. Med Decis Making. 2018;38(1s). doi:10.1177/0272989X17717981
-
(2018)
Med Decis Making
, vol.38
, Issue.1 s
-
-
Gangnon, R.E.1
Stout, N.K.2
Alagoz, O.3
Hampton, J.M.4
Sprague, B.L.5
Trentham-Dietz, A.6
-
19
-
-
85040615046
-
Collaborative modeling of US breast cancer screening strategies
-
Accessed May 1, 2015
-
Mandelblatt JS, Cronin K, de Koning H, Miglioretti DL, Schechter CS, Stout N. Collaborative modeling of US breast cancer screening strategies: AHRQ publication No 14-05201-EF-4. https://www.uspreventiveservicestaskforce.org/Page/Document/modeling-report-collaborative -modeling-of-us-breast-cancer-1/breast-cancer -screening1. Accessed May 1, 2015.
-
AHRQ Publication No 14-05201-EF-4
-
-
Mandelblatt, J.S.1
Cronin, K.2
De Koning, H.3
Miglioretti, D.L.4
Schechter, C.S.5
Stout, N.6
-
20
-
-
85019271426
-
-
National Cancer Institute, DCCPS, Surveillance Research Program. Released December Accessed December 14, 2017
-
Surveillance, Epidemiology, and End Results (SEER) Program. SEER∗Stat database: mortality—all COD, aggregated with state, total US (1969-2014) , National Cancer Institute, DCCPS, Surveillance Research Program. Released December 2016. https://www.seer.cancer.gov/. Accessed December 14, 2017.
-
(2016)
SEER∗Stat Database: Mortality—All COD, Aggregated with State, Total US (1969-2014)
-
-
-
21
-
-
0004280716
-
-
Health Statistics. Accessed March 31, 2017
-
National Center for Health Statistics. Compressed mortality file. https://www.cdc.gov/nchs/data_access/cmf.htm. Accessed March 31, 2017.
-
Compressed Mortality File
-
-
-
22
-
-
85040578878
-
Common model inputs used in CISNET collaborative breast cancer modeling
-
Mandelblatt JS, Near AM, Miglioretti DL, et al. Common model inputs used in CISNET collaborative breast cancer modeling. Med Decis Making. 2018;38(1s). doi:10.1177 /0272989X17700624
-
(2018)
Med Decis Making
, vol.38
, Issue.1 s
-
-
Mandelblatt, J.S.1
Near, A.M.2
Miglioretti, D.L.3
-
23
-
-
34249105998
-
Additional common inputs for analyzing impact of adjuvant therapy and mammography on US mortality
-
Cronin KA, Mariotto AB, Clarke LD, Feuer EJ. Additional common inputs for analyzing impact of adjuvant therapy and mammography on US mortality. J Natl Cancer Inst Monogr. 2006;(36):26-29.
-
(2006)
J Natl Cancer Inst Monogr
, vol.36
, pp. 26-29
-
-
Cronin, K.A.1
Mariotto, A.B.2
Clarke, L.D.3
Feuer, E.J.4
-
24
-
-
23444445202
-
Modeling the dissemination of mammography in the United States
-
Cronin KA, Yu B, Krapcho M, et al. Modeling the dissemination of mammography in the United States. Cancer Causes Control. 2005;16(6):701-712.
-
(2005)
Cancer Causes Control
, vol.16
, Issue.6
, pp. 701-712
-
-
Cronin, K.A.1
Yu, B.2
Krapcho, M.3
-
26
-
-
85040562269
-
Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for
-
Mariotto A, Feuer EJ, Harlan LC, Wun LM, Johnson KA, Abrams J. Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for
-
-
-
Mariotto, A.1
Feuer, E.J.2
Harlan, L.C.3
Wun, L.M.4
Johnson, K.A.5
Abrams, J.6
-
27
-
-
0037032510
-
Breast cancer in the United States: 1975-1999
-
breast cancer in the United States: 1975-1999. J Natl Cancer Inst. 2002;94(21):1626-1634.
-
(2002)
J Natl Cancer Inst
, vol.94
, Issue.21
, pp. 1626-1634
-
-
-
28
-
-
39049180984
-
Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999
-
Mariotto AB, Feuer EJ, Harlan LC, Abrams J. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999. J Natl Cancer Inst Monogr. 2006;(36):7-15.
-
(2006)
J Natl Cancer Inst Monogr
, vol.36
, pp. 7-15
-
-
Mariotto, A.B.1
Feuer, E.J.2
Harlan, L.C.3
Abrams, J.4
-
29
-
-
77951441901
-
-
Accessed January 1, 2015
-
US Food and Drug Administration. Mammography Quality Standards Act and program. https://www.fda.gov/Radiation-EmittingProducts/MammographyQualityStandardsActandProgram /default.htm. Accessed January 1, 2015.
-
Mammography Quality Standards Act and Program
-
-
-
31
-
-
24644454676
-
The effect of changes in tumor size on breast carcinoma survival in the US: 1975-1999
-
Elkin EB, Hudis C, Begg CB, Schrag D. The effect of changes in tumor size on breast carcinoma survival in the US: 1975-1999. Cancer. 2005;104(6):1149-1157.
-
(2005)
Cancer
, vol.104
, Issue.6
, pp. 1149-1157
-
-
Elkin, E.B.1
Hudis, C.2
Begg, C.B.3
Schrag, D.4
-
32
-
-
0029933489
-
Breast cancer mortality rates are levelling off or beginning to decline in many western countries: Analysis of time trends, age-cohort and age-period models of breast cancer mortality in 20 countries
-
Hermon C, Beral V. Breast cancer mortality rates are levelling off or beginning to decline in many western countries: analysis of time trends, age-cohort and age-period models of breast cancer mortality in 20 countries. Br J Cancer. 1996;73(7): 955-960.
-
(1996)
Br J Cancer
, vol.73
, Issue.7
, pp. 955-960
-
-
Hermon, C.1
Beral, V.2
-
33
-
-
0034690750
-
UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years
-
Peto R, Boreham J, Clarke M, Davies C, Beral V. UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years. Lancet. 2000;355 (9217):1822.
-
(2000)
Lancet
, vol.355
, Issue.9217
, pp. 1822
-
-
Peto, R.1
Boreham, J.2
Clarke, M.3
Davies, C.4
Beral, V.5
-
34
-
-
84958826817
-
Improvements in US breast cancer survival and proportion explained by tumor size and estrogen-receptor status
-
Park JH, Anderson WF, Gail MH. Improvements in US breast cancer survival and proportion explained by tumor size and estrogen-receptor status. J Clin Oncol. 2015;33(26):2870-2876.
-
(2015)
J Clin Oncol
, vol.33
, Issue.26
, pp. 2870-2876
-
-
Park, J.H.1
Anderson, W.F.2
Gail, M.H.3
-
35
-
-
27344458270
-
Diagnostic performance of digital versus film mammography for breast-cancer screening
-
Pisano ED, Gatsonis C, Hendrick E, et al; Digital Mammographic Imaging Screening Trial (DMIST) Investigators Group. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med. 2005;353(17):1773-1783.
-
(2005)
N Engl J Med
, vol.353
, Issue.17
, pp. 1773-1783
-
-
Pisano, E.D.1
Gatsonis, C.2
Hendrick, E.3
-
36
-
-
84905190986
-
Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography
-
Stout NK, Lee SJ, Schechter CB, et al. Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography. J Natl Cancer Inst. 2014;106(6):dju092.
-
(2014)
J Natl Cancer Inst
, vol.106
, Issue.6
, pp. dju092
-
-
Stout, N.K.1
Lee, S.J.2
Schechter, C.B.3
-
37
-
-
84902770556
-
Breast cancer screening using tomosynthesis in combination with digital mammography
-
Friedewald SM, Rafferty EA, Rose SL, et al. Breast cancer screening using tomosynthesis in combination with digital mammography. JAMA. 2014;311(24):2499-2507.
-
(2014)
JAMA
, vol.311
, Issue.24
, pp. 2499-2507
-
-
Friedewald, S.M.1
Rafferty, E.A.2
Rose, S.L.3
-
38
-
-
84889257564
-
Digitalbreasttomosynthesis andthechallengesofimplementinganemerging breastcancerscreeningtechnologyintoclinical practice
-
LeeCI,LehmanCD
-
LeeCI,LehmanCD.Digitalbreasttomosynthesis andthechallengesofimplementinganemerging breastcancerscreeningtechnologyintoclinical practice.JAmCollRadiol.2013;10(12):913-917.
-
(2013)
JAmCollRadiol
, vol.10
, Issue.12
, pp. 913-917
-
-
-
39
-
-
84905163505
-
US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status
-
Howlader N, Altekruse SF, Li CI, et al. US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status. J Natl Cancer Inst. 2014;106(5):dju055.
-
(2014)
J Natl Cancer Inst
, vol.106
, Issue.5
, pp. dju055
-
-
Howlader, N.1
Altekruse, S.F.2
Li, C.I.3
-
40
-
-
34249033328
-
Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis
-
Jatoi I, Chen BE, Anderson WF, Rosenberg PS. Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis. J Clin Oncol. 2007;25(13):1683-1690.
-
(2007)
J Clin Oncol
, vol.25
, Issue.13
, pp. 1683-1690
-
-
Jatoi, I.1
Chen, B.E.2
Anderson, W.F.3
Rosenberg, P.S.4
-
41
-
-
84942239431
-
Estrogen receptor status and the future burden of invasive and in situ breast cancers in the United States
-
pii:djv159
-
Rosenberg PS, Barker KA, Anderson WF. Estrogen receptor status and the future burden of invasive and in situ breast cancers in the United States. J Natl Cancer Inst. 2015;107(9):pii:djv159.
-
(2015)
J Natl Cancer Inst
, vol.107
, Issue.9
-
-
Rosenberg, P.S.1
Barker, K.A.2
Anderson, W.F.3
-
42
-
-
84920973831
-
Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States
-
Iqbal J, Ginsburg O, Rochon PA, Sun P, Narod SA. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States. JAMA. 2015;313(2): 165-173.
-
(2015)
JAMA
, vol.313
, Issue.2
, pp. 165-173
-
-
Iqbal, J.1
Ginsburg, O.2
Rochon, P.A.3
Sun, P.4
Narod, S.A.5
|